|Gene-expression profiles in hereditary breast cancer|
I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ...
New England Journal of Medicine 344 (8), 539-548, 2001
|DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis|
M Esteller, MF Fraga, M Guo, J Garcia-Foncillas, I Hedenfalk, AK Godwin, ...
Human molecular genetics 10 (26), 3001-3007, 2001
|Molecular classification of familial non-BRCA1/BRCA2 breast cancer|
I Hedenfalk, M Ringnér, A Ben-Dor, Z Yakhini, Y Chen, G Chebil, R Ach, ...
Proceedings of the National Academy of Sciences 100 (5), 2532-2537, 2003
|RNA quality in frozen breast cancer samples and the influence on gene expression analysis–a comparison of three evaluation methods using microcapillary electrophoresis traces|
C Strand, J Enell, I Hedenfalk, M Fernö
BMC molecular biology 8 (1), 38, 2007
|MYB oncogene amplification in hereditary BRCA1 breast cancer|
P Kauraniemi, I Hedenfalk, K Persson, DJ Duggan, M Tanner, ...
Cancer research 60 (19), 5323-5328, 2000
|An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression|
A Palazon, PA Tyrakis, D Macias, P Veliça, H Rundqvist, S Fitzpatrick, ...
Cancer cell 32 (5), 669-683. e5, 2017
|Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program|
F Cardoso, JMS Bartlett, L Slaets, CHM Van Deurzen, ...
Annals of Oncology 29 (2), 405-417, 2018
|Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk|
N Orr, A Lemnrau, R Cooke, O Fletcher, K Tomczyk, M Jones, N Johnson, ...
Nature genetics 44 (11), 1182-1184, 2012
|Clinical and molecular complexity of breast cancer metastases|
S Kimbung, N Loman, I Hedenfalk
Seminars in cancer biology 35, 85-95, 2015
|Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker|
I Johansson, C Nilsson, P Berglund, M Lauss, M Ringnér, H Olsson, ...
Breast Cancer Research 14 (1), R31, 2012
|Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer|
K Rennstam, N McMichael, P Berglund, G Honeth, C Hegardt, L Rydén, ...
Breast cancer research and treatment 122 (2), 315-324, 2010
|Gene expression in inherited breast cancer|
IA Hedenfalk, M Ringnér, JM Trent, A Borg
Academic Press 84, 1-34, 2002
|High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer|
I Johansson, C Nilsson, P Berglund, C Strand, G Jönsson, J Staaf, ...
Breast cancer research and treatment 129 (3), 747-760, 2011
|Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival|
NP Tobin, JC Harrell, J Lövrot, S Egyhazi Brage, M Frostvik Stolt, ...
Annals of oncology 26 (1), 81-88, 2015
|Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition|
S Kimbung, E Biskup, I Johansson, K Aaltonen, A Ottosson-Wadlund, ...
Cancer letters 319 (2), 232-241, 2012
|Microarrays in breast cancer research and clinical practice–the future lies ahead|
SK Gruvberger-Saal, HE Cunliffe, KM Carr, IA Hedenfalk
Endocrine-related cancer 13 (4), 1017-1031, 2006
|Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial|
M Feldt, O Bjarnadottir, S Kimbung, K Jirström, PO Bendahl, S Veerla, ...
Journal of translational medicine 13 (1), 1-11, 2015
|Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier|
OT Johannsson, S Staff, J Vallon-Christersson, S Kytöla, T Gudjonsson, ...
Laboratory investigation 83 (3), 387-396, 2003
|Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact|
C Nilsson, I Johansson, C Ahlin, S Thorstenson, RM Amini, M Holmqvist, ...
Acta Oncologica, 2012
|ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ER α: a combination therapy potentially targeting hypoxic and …|
Å Kronblad, I Hedenfalk, E Nilsson, S Påhlman, G Landberg
Oncogene 24 (45), 6835-6841, 2005